Orchestra BioMed Holdings (OBIO) Cash & Equivalents Growth (3y) (2023 - 2026)
Orchestra BioMed Holdings (OBIO) Cash & Equivalents Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 13.29% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.63% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -16.07% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.88% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Orchestra BioMed Holdings | 235.83 Mn | 141.43 Mn | 78,000.00 | 14.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.91% |
| Dec 31, 2025 | 62.32% |
| Sep 30, 2025 | 285.17% |
| Jun 30, 2025 | 143.00% |
| Mar 31, 2025 | 134.72% |
| Dec 31, 2024 | 218.71% |
| Sep 30, 2024 | 212.75% |
| Jun 30, 2024 | 204.44% |
| Mar 31, 2024 | 128.68% |
| Dec 31, 2023 | 147.04% |